Skip to main content

DiaMedica Therapeutics Inc.

DMAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401040

No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in DiaMedica Therapeutics Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
38
+3 vs. Q3 2023
Shares held
3.84M
−240.0K (−5.9%) vs. Q3 2023
Total value
$10.9M
+$380.5K (+3.6%) vs. Q3 2023
New holders
6
12 more added
Sold out
3
4 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DMAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 38 institutions
Q1 2021: 41 institutionsQ2 2021: 43 institutionsQ3 2021: 34 institutionsQ4 2021: 39 institutionsQ1 2022: 34 institutionsQ2 2022: 28 institutionsQ3 2022: 26 institutionsQ4 2022: 28 institutionsQ1 2023: 25 institutionsQ2 2023: 32 institutionsQ3 2023: 36 institutionsQ4 2023: 38 institutionsQ1 2024: 32 institutionsQ2 2024: 32 institutionsQ3 2024: 40 institutionsQ4 2024: 45 institutionsQ1 2025: 57 institutionsQ2 2025: 58 institutionsQ3 2025: 78 institutionsQ4 2025: 92 institutionsQ1 2026: 99 institutionsQ2 2026: 88 institutions
Value heldQ4 2023: $11.3M
Q1 2021: $52.1MQ2 2021: $16.9MQ3 2021: $11.2MQ4 2021: $15.0MQ1 2022: $10.0MQ2 2022: $7.42MQ3 2022: $3.14MQ4 2022: $3.99MQ1 2023: $3.93MQ2 2023: $15.1MQ3 2023: $11.0MQ4 2023: $11.3MQ1 2024: $13.2MQ2 2024: $14.9MQ3 2024: $23.3MQ4 2024: $36.6MQ1 2025: $28.5MQ2 2025: $34.5MQ3 2025: $82.9MQ4 2025: $96.0MQ1 2026: $79.6MQ2 2026: $87.8M
Institutions holding DMAC and their total value by quarter
QuarterHoldersValue
Q2 202688$87.8M
Q1 202699$79.6M
Q4 202592$96.0M
Q3 202578$82.9M
Q2 202558$34.5M
Q1 202557$28.5M
Q4 202445$36.6M
Q3 202440$23.3M
Q2 202432$14.9M
Q1 202432$13.2M
Q4 202338$11.3M
Q3 202336$11.0M
Q2 202332$15.1M
Q1 202325$3.93M
Q4 202228$3.99M
Q3 202226$3.14M
Q2 202228$7.42M
Q1 202234$10.0M
Q4 202139$15.0M
Q3 202134$11.2M
Q2 202143$16.9M
Q1 202141$52.1M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding DiaMedica Therapeutics Inc.; share changes are against Q3 2023.

Institutions holding DMAC in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Cooperman Leon G883,623$2.51M0.12%+7,630+0.9%Added
Vanguard Group Inc802,171$2.28M0.00%+13,382+1.7%Added
Paragon Associates & Paragon Associates II Joint Venture500,000$1.42M3.26%+30,000+6.4%Added
Altium Capital Management LP287,698$817.1K0.56%−208,302−42.0%Reduced
Bleichroeder LP222,317$631.4K0.14%00.0%Unchanged
Geode Capital Management, LLC218,778$621.5K0.00%00.0%Unchanged
Northern Trust Corp133,633$379.5K0.00%+43,933+49.0%Added
Morgan Stanley120,995$343.6K0.00%+27,195+29.0%Added
First Manhattan Co114,744$325.9K0.00%00.0%Unchanged
Aristides Capital LLC106,333$302.0K0.15%00.0%Unchanged
BlackRock Inc.104,732$297.4K0.00%+3,007+3.0%Added
State Street Corp66,629$189.2K0.00%00.0%Unchanged
Catalyst Financial Partners LLC36,267$103.0K0.03%00.0%Unchanged
Bank of New York Mellon Corp34,233$97.2K0.00%−384−1.1%Reduced
Millennium Management LLC28,845$81.9K0.00%+173+0.6%Added
Susquehanna International Group, LLP27,619$78.4K0.00%+27,619New
Jane Street Group, LLC23,761$67.5K0.00%+23,761New
Citadel Advisors LLC22,715$64.5K0.00%+6,847+43.1%Added
Stonebridge Capital Advisors LLC20,000$56.8K0.01%00.0%Unchanged
Dimensional Fund Advisors LP16,959$48.2K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA14,000$39.8K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc13,251$37.6K0.00%00.0%Unchanged
Avantax Advisory Services, Inc.12,500$35.5K0.00%+12,500New
Tower Research Capital LLC (TRC)7,264$20.6K0.00%+3,503+93.1%Added
Group One Trading, L.P.4,843$13.8K0.00%+4,843New
Massmutual Trust Co FSB4,824$13.7K0.00%00.0%Unchanged
US Bancorp4,335$12.3K0.00%00.0%Unchanged
Naples Money Management LLC3,878$11.0K0.01%+3,878New
TD Waterhouse Canada Inc.1,070$4.05K0.00%−500−31.8%Reduced
Royal Bank of Canada1,082$3.00K0.00%+277+34.4%Added
Advisor Group Holdings, Inc.1,000$2.84K0.00%00.0%Unchanged
Legend Financial Advisors, Inc.1,000$2.84K0.00%00.0%Unchanged
JPMorgan Chase & Co564$1.60K0.00%+539+2,156.0%Added
Simplex Trading, LLC481$1.00K0.00%−539−52.8%Reduced
Federation des caisses Desjardins du Quebec230$6530.00%00.0%Unchanged
Wells Fargo & Company172$4880.00%+9+5.5%Added
Toronto Dominion Bank24$680.00%00.0%Unchanged
Bank of America Corp15$430.00%+15New
EAM Investors, LLC0$00.00%−212,512−100.0%Sold out
Marshall Wace, LLP0$00.00%−26,745−100.0%Sold out
UBS Group AG0$00.00%−84−100.0%Sold out
Jacob Asset Management of New York LLC––––Not filed